TEVATeva Pharmaceutical Industries LimitedApr 29, 2026Q1 2026
Read transcript →Teva Pharmaceutical Industries Limited (TEVA) Earnings Call Transcripts
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$34.57
+0.03%
Mkt Cap $36.69B
TEVATeva Pharmaceutical Industries LimitedApr 29, 2026TEVATeva Pharmaceutical Industries LimitedJan 28, 2026Q4 2025
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 5, 2025Q3 2025
Read transcript →TEVATeva Pharmaceutical Industries LimitedJul 30, 2025Q2 2025
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 7, 2025Q1 2025
Read transcript →TEVATeva Pharmaceutical Industries LimitedJan 29, 2025Q4 2024
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 6, 2024Q3 2024
Read transcript →TEVATeva Pharmaceutical Industries LimitedJul 31, 2024Q2 2024
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 8, 2024Q1 2024
Read transcript →TEVATeva Pharmaceutical Industries LimitedJan 31, 2024Q4 2023
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 8, 2023Q3 2023
Read transcript →TEVATeva Pharmaceutical Industries LimitedAug 2, 2023Q2 2023
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 10, 2023Q1 2023
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 8, 2023Q4 2022
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 3, 2022Q3 2022
Read transcript →TEVATeva Pharmaceutical Industries LimitedJul 27, 2022Q2 2022
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 3, 2022Q1 2022
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 9, 2022Q4 2021
Read transcript →TEVATeva Pharmaceutical Industries LimitedOct 27, 2021Q3 2021
Read transcript →TEVATeva Pharmaceutical Industries LimitedJul 28, 2021Q2 2021
Read transcript →TEVATeva Pharmaceutical Industries LimitedApr 28, 2021Q1 2021
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 10, 2021Q4 2020
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 5, 2020Q3 2020
Read transcript →TEVATeva Pharmaceutical Industries LimitedAug 5, 2020Q2 2020
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 7, 2020Q1 2020
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 12, 2020Q4 2019
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 7, 2019Q3 2019
Read transcript →TEVATeva Pharmaceutical Industries LimitedAug 7, 2019Q2 2019
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 2, 2019Q1 2019
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 13, 2019Q4 2018
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 1, 2018Q3 2018
Read transcript →TEVATeva Pharmaceutical Industries LimitedAug 2, 2018Q2 2018
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 3, 2018Q1 2018
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 8, 2018Q4 2017
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 2, 2017Q3 2017
Read transcript →TEVATeva Pharmaceutical Industries LimitedAug 3, 2017Q2 2017
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 12, 2017Q1 2017
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 13, 2017Q4 2016
Read transcript →TEVATeva Pharmaceutical Industries LimitedNov 15, 2016Q3 2016
Read transcript →TEVATeva Pharmaceutical Industries LimitedAug 4, 2016Q2 2016
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 9, 2016Q1 2016
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 12, 2016Q4 2015
Read transcript →TEVATeva Pharmaceutical Industries LimitedOct 29, 2015Q3 2015
Read transcript →TEVATeva Pharmaceutical Industries LimitedJul 30, 2015Q2 2015
Read transcript →TEVATeva Pharmaceutical Industries LimitedApr 30, 2015Q1 2015
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 5, 2015Q4 2014
Read transcript →TEVATeva Pharmaceutical Industries LimitedOct 30, 2014Q3 2014
Read transcript →TEVATeva Pharmaceutical Industries LimitedJul 31, 2014Q2 2014
Read transcript →TEVATeva Pharmaceutical Industries LimitedMay 1, 2014Q1 2014
Read transcript →TEVATeva Pharmaceutical Industries LimitedFeb 6, 2014Q4 2013
Read transcript →